Faculty

Stephen Schwartz

Professor, Epidemiology

206-685-1799
stevesch@uw.edu

Education

PhD Epidemiology, University of Washington, 1990
MPH Epidemiology, Yale University, 1984

Contact

206-685-1799
stevesch@uw.edu

Fred Hutchinson Cancer Research Center
Box 358080, Room M4-B863
1100 Fairview Ave N.,
PO Box 19024, Mailstop: M4-C308
Seattle, WA 98109
University of Washington
Dept. of Epidemiology
1959 NE Pacific Street
Health Sciences F-261F
Seattle, WA 98195

Research Interests

Dr. Schwartz primarily studies the etiology and outcomes of cancer. A major objective of his research is to determine the influence of genetic susceptibility, either alone or in combination with lifestyle and environmental risk factors. Current funded research projects include studies focusing on the genetic and non-genetic risk factors for HPV-cancers and testicular germ cell tumors. Other areas of cancer research focus on molecular markers for oral cancer outcomes and the health and well-being of adolescent and young adult cancer survivors. Among his other responsibilities in the field of cancer epidemiology, he serves as Principal Investigator of the Cancer Surveillance System, a population-based cancer registry at the Fred Hutchinson Cancer Research Center.

Recent Publications (PubMed)

Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer.
(2021 Sep 9)
Cancer Epidemiol 75(): 102020
Giraldi L, Collatuzzo G, Hashim D, Franceschi S, Herrero R, Chen C, Schwartz SM, Smith E, Kelsey K, McClean M, Gillison M, Boccia S, Hashibe M, Amy Lee YC, Boffetta P

Identification of 22 susceptibility loci associated with testicular germ cell tumors.
(2021 Jul 23)
Nat Commun 12(1): 4487
Pluta J, Pyle LC, Nead KT, Wilf R, Li M, Mitra N, Weathers B, D'Andrea K, Almstrup K, Anson-Cartwright L, Benitez J, Brown CD, Chanock S, Chen C, Cortessis VK, Ferlin A, Foresta C, Gamulin M, Gietema JA, Grasso C, Greene MH, Grotmol T, Hamilton RJ, Haugen TB, Hauser R, Hildebrandt MAT, Johnson ME, Karlsson R, Kiemeney LA, Lessel D, Lothe RA, Loud JT, Loveday C, Martin-Gimeno P, Meijer C, Nsengimana J, Quinn DI, Rafnar T, Ramdas S, Richiardi L, Skotheim RI, Stefansson K, Turnbull C, Vaughn DJ, Wiklund F, Wu X, Yang D, Zheng T, Wells AD, Grant SFA, Rajpert-De Meyts E, Schwartz SM, Bishop DT, McGlynn KA, Kanetsky PA, Nathanson KL, Testicular Cancer Consortium.

Cancer mortality in a population-based cohort of American Indians - The strong heart study.
(2021 Oct)
Cancer Epidemiol 74(): 101978
Rhoades DA, Farley J, Schwartz SM, Malloy KM, Wang W, Best LG, Zhang Y, Ali T, Yeh F, Rhoades ER, Lee E, Howard BV

Utilization of Systemic Therapy in Patients With Cancer Near the End of Life in the Pre- Versus Postimmune Checkpoint Inhibitor Eras.
(2021 May 19)
JCO Oncol Pract
Khaki AR, Chennupati S, Fedorenko C, Li L, Sun Q, Grivas P, Ramsey SD, Schwartz SM, Shankaran V

Genetically Inferred Telomere Length and Testicular Germ Cell Tumor Risk.
(2021 Jun)
Cancer Epidemiol Biomarkers Prev 30(6): 1275-1278
Brown DW, Lan Q, Rothman N, Pluta J, Almstrup K, Dalgaard MD, Greene MH, Grotmol T, Loveday C, Schwartz SM, Turnbull C, Wiklund F, Kanetsky PA, Nathanson KL, McGlynn KA, Machiela MJ, Testicular Cancer Consortium.

Show complete publication list